ALHC
Alignment Healthcare, Inc. · Healthcare · Medical - Healthcare Plans
动量输入(同类管理人):
持有人广度 +11.1% ·
股份流向 -11.7% ·
净新建仓位 +10.0%
· 公式
持有人分散化:持有人数增多,合计持仓比例缩小。
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q3 2024
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 104 | -4 | 153.25M | $3.65B | +8 | −12 |
| Q1 2026 | 111 | +15 | 140.61M | $2.43B | +19 | −5 |
| Q4 2025 | 96 | +1 | 127.62M | $2.52B | +2 | n/a |
| Q3 2025 | 20 | +1 | 84.25M | $1.47B | +1 | −1 |
| Q2 2025 | 17 | 0 | 71.35M | $998.91M | +1 | −1 |
| Q1 2025 | 14 | 0 | 21.82M | $406.29M | +2 | −2 |
| Q4 2024 | 14 | +3 | 25.36M | $285.33M | +3 | n/a |
| Q3 2024 | 10 | +1 | 10.84M | $128.16M | +2 | −1 |
| Q2 2024 | 9 | n/a | 12.27M | $95.98M | n/a | n/a |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 4.18M | -7.2% | $49.42M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 2 | Geode Capital Management ✦ (被动) | 2.44M | +1.4% | $28.88M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | Renaissance Technologies ✦ | 1.53M | -2.0% | $18.14M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.31M | +2403.5% | $15.50M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 5 | Millennium Management ✦ | 492.29K | -71.4% | $5.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 336.08K | +73.8% | $3.97M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 7 | Norges Bank ✦ (被动) | 332.83K | -22.8% | $3.93M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 118.70K | 新增 | $1.40M | 0.0% | New | 1 | SEC ↗ |
| 9 | Arrowstreet Capital ✦ | 63.16K | 新增 | $746,587 | 0.0% | New | 1 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 30.00K | -78.6% | $354,600 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例,即持仓信心指标。✦ = 精选管理人。
新增买入方
| D. E. Shaw & Co. | $1.40M | 0.0% |
| Arrowstreet Capital | $746,587 | 0.0% |
已清仓
| Citadel Advisors | $9.83M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 290 持有人, 201.46M 股份, $3.20B 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
持有该证券的受追踪机构最常同时持有的其他证券:基于共同持有计数,而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Officer · 32.48K 股 · $269,576
Officer, Director · 23.51K 股 · $202,430
Officer, Director · 27.40K 股 · $356,200
Officer · 122.71K 股 · $1.56M
Officer, Director · 385.27K 股 · $4.89M
Officer, Director · 172.60K 股 · $2.24M
Officer · 5.00K 股 · $70,000
Officer, Director · 298.00K 股 · $4.14M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论